Clinical trial
Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection Fraction
NCT05387967 is registered in ClinicalTrials.gov with National Institute of Cardiovascular Diseases, Pakistan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection Fraction
- Lead sponsor
- National Institute of Cardiovascular Diseases, Pakistan
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 1, 2021
- Completion date
- September 30, 2021
- Enrollment
- 121 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.